Serum levels of free kappa and lambda immunoglobulin light chains were measured at the start of the study. The primary end point was mortality from any cause. Results: In survivors, median serum levels of free kappa plus lambda immunoglobulin light chains were significantly higher compared with nonsurvivors (p < 0.05). Survival was significantly longer in those patients who had serum levels of free kappa plus lambda immunoglobulin light chains

above the median compared with patients with serum levels below the median of 210 mg/l (chi(2) EX 527 mouse = 5.91; p = 0.015 by log-rank, Mantel-Cox, test). We performed univariate and multivariate regression analysis showing that older age and lower serum levels of free kappa plus lambda immunoglobulin light chains predicted mortality in hemodialysis patients. Conclusion: Higher serum levels of free kappa plus lambda immunoglobulin light chains

ameliorate survival in hemodialysis patients. Copyright (C) 2011 S. Karger AG, Basel”
“Human www.selleckchem.com/products/pexidartinib-plx3397.html studies of neurodevelopment suggest that children exposed in utero to certain antiepileptic drugs (AEDs) suffer a variety of brain-behavior sequelae, such as neural tube defects, developmental delays, cognitive deficits, etc. Valproic acid (VPA), a commonly used AED, has greater risk for these side effects compared with other AEDs. However, the detailed molecular mechanisms underlying this developmental neurotoxicity of VPA is unclear despite previous research demonstrating that VPA could induce widespread apoptotic neurodegeneration in developing brains of animal models. This study characterizes the role of astrocytes in VPA-induced neurodegeneration. In developing brains, we evaluated the developmental neurotoxicity of VPA on differentiating neurons and astrocytes from neural progenitor cells cultured from the hippocampus of human fetuses. Exposure of a neuron-enriched culture to VPA at 250 mu M or 500 mu M did not cause neuronal apoptosis,

Methocarbamol but at 1 mM and 7 days exposure, a slight increase in the percentage of apoptotic cells was observed. In contrast, VPA at 250 mu M to 1 mM, selectively induced neuronal apoptosis in a neuron-astrocyte mixed cell culture model. The VPA-treated astrocytes showed morphological changes; and the level of tumor necrosis factor-alpha (TNF-alpha) was elevated in the supernatant. Both neuronal apoptosis and TNF-alpha release from astrocytes increased with concentration and exposure time to VPA, suggesting a synergism between the two cell types. Treatment of the neuron-astrocyte mixed culture exposed to VPA with TNF-alpha antibody partly prevented neuronal apoptosis, while the addition of exogenous TNF-alpha induced apoptosis in both cultures. Moreover, this pro-apoptotic effect was specific to VPA, as another AED, valpromide, failed to mimic this pro-apoptotic effect, nor did an inhibitor of histone deacetylase (iHDAC), sodium butyrate (NaB).